A Comparison of the Pacemaker Automatic Features in Reduction of Ventricular Pacing
NCT ID: NCT01039467
Last Updated: 2020-02-05
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
385 participants
INTERVENTIONAL
2009-06-30
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Factors Affecting Selection of Leadless Pacemaker and Atrioventricular Synchronous Pacing Status
NCT06587672
Application of Right Atrial Left Ventricular Fusion Pacing in Patients With CRT Indications
NCT03071978
Adapta Pacing System Clinical Study
NCT00307073
Optimize RV Follow-up Selective Site Pacing Clinical Trial
NCT00949715
Optimal Pacing Rate for Cardiac Resynchronization Therapy
NCT06445439
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Medtronic Adapta® pacemakers include Managed Ventricular Pacing®, a pacing mode designed to promote intrinsic conduction, and also Search AV™+, a feature designed to reduce unnecessary ventricular pacing in patients with intact or intermittent AV conduction.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Managed Ventricular Pacing
Managed Ventricular Pacing group: programmed on
Medtronic Adapta Dual Chamber Pacemaker
Medtronic Adapta Dual Chamber Pacemaker
Search AV+
Search AV+: programmed on
Medtronic Adapta Dual Chamber Pacemaker
Medtronic Adapta Dual Chamber Pacemaker
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medtronic Adapta Dual Chamber Pacemaker
Medtronic Adapta Dual Chamber Pacemaker
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Class I or Class IIa pacemaker indication
* Geographically stable and available for follow-up at the center for the length of the study
* Age greater than 18
* To be implanted with Adapta dual chamber pacemaker
Exclusion Criteria
* Patient with a previously implanted pacemaker/Implantable Cardioverter-Defibrillator (ICD)/Cardiac Resynchronization Therapy (CRT) device
* Life expectancy of less than one year
* Patient has a mechanical tricuspid heart valve
* Medical conditions that preclude the testing requirement by the protocol or limit study participation
* Patient has persistent 3rd degree atrioventricular (AV) block
* Patient has persistent atrial fibrillation (AF)
* Patient has neurogenic syncope
* Patient has carotid sinus syndrome
* Patient has hypertrophic obstructive cardiomyopathy
* Inclusion in another clinical trial or study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shu Zhang, PhD
Role: PRINCIPAL_INVESTIGATOR
Chinese Academy of Medical Sciences, Fuwai Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
3rd Hospital of Beijing University
Beijing, Beijing Municipality, China
Anzhen Hospital
Beijing, Beijing Municipality, China
Beijing Hospital
Beijing, Beijing Municipality, China
Fuwai Hospital
Beijing, Beijing Municipality, China
Fujian Province Hospital
Fuzhou, Fujian, China
1st Hospital of Zhongshan Medical University
Guangzhou, Guangdong, China
2nd Hospital of Zhongshan Medical University
Guangzhou, Guangdong, China
Guangdong Province People's Hospital
Guangzhou, Guangdong, China
1st Hospital of Zhengzhou University
Zhengzhou, Henan, China
Wuhan Asian Heart Hospital
Wuhan, Hubei, China
Wuhan Union Hospital
Wuhan, Hubei, China
Xiangya Second Hospital, Central South University
Changsha, Hunan, China
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China
2nd Hospital of Jilin University
Changchun, Jilin, China
Liaoning Province People's Hospital
Shenyang, Liaoning, China
Affiliated Hospital of Qingdao Medical College
Qingdao, Shandong, China
Shanghai Huadong Hospital
Shanghai, Shanghai Municipality, China
Shanghai Minhang District Hospital
Shanghai, Shanghai Municipality, China
General Hospital of Tianjin Medical University
Tianjin, Tianjin Municipality, China
Tianjin Chest Hospital
Tianjin, Tianjin Municipality, China
First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China
Xinjiang Automatic District Hospital
Ürümqi, Xinjiang, China
1st Hospital of Kunming Medical College
Kunming, Yunnan, China
Yunnan Province 1st People's Hospital
Kunming, Yunnan, China
Yuxi People's Hospital
Yuxi, Yunnan, China
1st Hospital of Medical College, Zhejiang University
Hangzhou, Zhejiang, China
2nd Hospital of Medical College, Zhejiang University
Hangzhou, Zhejiang, China
Hangzhou First People's Hospital
Hangzhou, Zhejiang, China
Zhejiang Hospital
Hangzhou, Zhejiang, China
Shanghai First People's Hospital
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COMPARE Study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.